By Drug Class / Mechanism

Botulinum Toxin (Type A & B, Cosmetic & Functional) Market Analysis

Cross-industry research covering Botulinum Toxin (Type A & B, Cosmetic & Functional) across 1 market reportspanning Pharmaceuticals & Medical Devices — Ophthalmic Surgery.

1 Reports

1 Industries

Reports Covering Botulinum Toxin (Type A & B, Cosmetic & Functional)

Oculoplastic Surgery Market to Reach USD 8.4 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Medical Devices — Ophthalmic Surgery·Market: USD 4.8 Billion (2025)·CAGR: 7.2%

Allergan's onabotulinumtoxinA (Botox) retains dominant share in periocular cosmetic and functional indications including blepharospasm; biosimilar and biogeneric competition is intensifying with CDER-approved interchangeable products entering the market from 2023 onward, though switching in physician-administered settings remains slower than in other biologics classes.

16%

Market Share

6.1%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments